These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
192 related articles for article (PubMed ID: 19141695)
1. Prolonged saturated fat-induced, glucose-dependent insulinotropic polypeptide elevation is associated with adipokine imbalance and liver injury in nonalcoholic steatohepatitis: dysregulated enteroadipocyte axis as a novel feature of fatty liver. Musso G; Gambino R; Pacini G; De Michieli F; Cassader M Am J Clin Nutr; 2009 Feb; 89(2):558-67. PubMed ID: 19141695 [TBL] [Abstract][Full Text] [Related]
2. Transcription factor 7-like 2 polymorphism modulates glucose and lipid homeostasis, adipokine profile, and hepatocyte apoptosis in NASH. Musso G; Gambino R; Pacini G; Pagano G; Durazzo M; Cassader M Hepatology; 2009 Feb; 49(2):426-35. PubMed ID: 19105201 [TBL] [Abstract][Full Text] [Related]
3. Nonalcoholic steatohepatitis versus steatosis: adipose tissue insulin resistance and dysfunctional response to fat ingestion predict liver injury and altered glucose and lipoprotein metabolism. Musso G; Cassader M; De Michieli F; Rosina F; Orlandi F; Gambino R Hepatology; 2012 Sep; 56(3):933-42. PubMed ID: 22684858 [TBL] [Abstract][Full Text] [Related]
4. Adiponectin gene polymorphisms modulate acute adiponectin response to dietary fat: Possible pathogenetic role in NASH. Musso G; Gambino R; De Michieli F; Durazzo M; Pagano G; Cassader M Hepatology; 2008 Apr; 47(4):1167-77. PubMed ID: 18311774 [TBL] [Abstract][Full Text] [Related]
5. Effect of lectin-like oxidized LDL receptor-1 polymorphism on liver disease, glucose homeostasis, and postprandial lipoprotein metabolism in nonalcoholic steatohepatitis. Musso G; Cassader M; De Michieli F; Saba F; Bo S; Gambino R Am J Clin Nutr; 2011 Oct; 94(4):1033-42. PubMed ID: 21865331 [TBL] [Abstract][Full Text] [Related]
6. Impact of sterol regulatory element-binding factor-1c polymorphism on incidence of nonalcoholic fatty liver disease and on the severity of liver disease and of glucose and lipid dysmetabolism. Musso G; Bo S; Cassader M; De Michieli F; Gambino R Am J Clin Nutr; 2013 Oct; 98(4):895-906. PubMed ID: 23985808 [TBL] [Abstract][Full Text] [Related]
7. Lipoprotein metabolism mediates the association of MTP polymorphism with beta-cell dysfunction in healthy subjects and in nondiabetic normolipidemic patients with nonalcoholic steatohepatitis. Musso G; Gambino R; Cassader M J Nutr Biochem; 2010 Sep; 21(9):834-40. PubMed ID: 19733470 [TBL] [Abstract][Full Text] [Related]
8. Adipokines in NASH: postprandial lipid metabolism as a link between adiponectin and liver disease. Musso G; Gambino R; Durazzo M; Biroli G; Carello M; Fagà E; Pacini G; De Michieli F; Rabbione L; Premoli A; Cassader M; Pagano G Hepatology; 2005 Nov; 42(5):1175-83. PubMed ID: 16231364 [TBL] [Abstract][Full Text] [Related]
9. Minor Contribution of Endogenous GLP-1 and GLP-2 to Postprandial Lipemia in Obese Men. Matikainen N; Björnson E; Söderlund S; Borén C; Eliasson B; Pietiläinen KH; Bogl LH; Hakkarainen A; Lundbom N; Rivellese A; Riccardi G; Després JP; Alméras N; Holst JJ; Deacon CF; Borén J; Taskinen MR PLoS One; 2016; 11(1):e0145890. PubMed ID: 26752550 [TBL] [Abstract][Full Text] [Related]
10. MERTK rs4374383 variant predicts incident nonalcoholic fatty liver disease and diabetes: role of mononuclear cell activation and adipokine response to dietary fat. Musso G; Cassader M; De Michieli F; Paschetta E; Pinach S; Saba F; Bongiovanni D; Framarin L; Berrutti M; Leone N; Corvisieri S; Parente R; Molinaro F; Sircana A; Bo S; Gambino R Hum Mol Genet; 2017 May; 26(9):1747-1758. PubMed ID: 28334911 [TBL] [Abstract][Full Text] [Related]
11. TM6SF2 rs58542926 variant affects postprandial lipoprotein metabolism and glucose homeostasis in NAFLD. Musso G; Cipolla U; Cassader M; Pinach S; Saba F; De Michieli F; Paschetta E; Bongiovanni D; Framarin L; Leone N; Berrutti M; Rosina F; Corvisieri S; Molinaro F; Sircana A; Gambino R J Lipid Res; 2017 Jun; 58(6):1221-1229. PubMed ID: 28242789 [TBL] [Abstract][Full Text] [Related]
12. Dietary habits and their relations to insulin resistance and postprandial lipemia in nonalcoholic steatohepatitis. Musso G; Gambino R; De Michieli F; Cassader M; Rizzetto M; Durazzo M; Fagà E; Silli B; Pagano G Hepatology; 2003 Apr; 37(4):909-16. PubMed ID: 12668986 [TBL] [Abstract][Full Text] [Related]
13. Sterol regulatory element-binding factor 2 (SREBF-2) predicts 7-year NAFLD incidence and severity of liver disease and lipoprotein and glucose dysmetabolism. Musso G; Cassader M; Bo S; De Michieli F; Gambino R Diabetes; 2013 Apr; 62(4):1109-20. PubMed ID: 23274901 [TBL] [Abstract][Full Text] [Related]
14. Polymorphism in microsomal triglyceride transfer protein: a link between liver disease and atherogenic postprandial lipid profile in NASH? Gambino R; Cassader M; Pagano G; Durazzo M; Musso G Hepatology; 2007 May; 45(5):1097-107. PubMed ID: 17464986 [TBL] [Abstract][Full Text] [Related]
15. Enhanced GIP Secretion in Obesity Is Associated with Biochemical Alteration and miRNA Contribution to the Development of Liver Steatosis. Góralska J; Raźny U; Polus A; Dziewońska A; Gruca A; Zdzienicka A; Dembińska-Kieć A; Solnica B; Micek A; Kapusta M; Słowińska-Solnica K; Malczewska-Malec M Nutrients; 2020 Feb; 12(2):. PubMed ID: 32069846 [TBL] [Abstract][Full Text] [Related]
16. Association of liver disease with postprandial large intestinal triglyceride-rich lipoprotein accumulation and pro/antioxidant imbalance in normolipidemic non-alcoholic steatohepatitis. Musso G; Gambino R; De Michieli F; Biroli G; Fagà E; Pagano G; Cassader M Ann Med; 2008; 40(5):383-94. PubMed ID: 18484349 [TBL] [Abstract][Full Text] [Related]
17. Dairy proteins, dairy lipids, and postprandial lipemia in persons with abdominal obesity (DairyHealth): a 12-wk, randomized, parallel-controlled, double-blinded, diet intervention study. Bohl M; Bjørnshave A; Rasmussen KV; Schioldan AG; Amer B; Larsen MK; Dalsgaard TK; Holst JJ; Herrmann A; O'Neill S; O'Driscoll L; Afman L; Jensen E; Christensen MM; Gregersen S; Hermansen K Am J Clin Nutr; 2015 Apr; 101(4):870-8. PubMed ID: 25833983 [TBL] [Abstract][Full Text] [Related]
18. Fructose intervention for 12 weeks does not impair glycemic control or incretin hormone responses during oral glucose or mixed meal tests in obese men. Matikainen N; Söderlund S; Björnson E; Bogl LH; Pietiläinen KH; Hakkarainen A; Lundbom N; Eliasson B; Räsänen SM; Rivellese A; Patti L; Prinster A; Riccardi G; Després JP; Alméras N; Holst JJ; Deacon CF; Borén J; Taskinen MR Nutr Metab Cardiovasc Dis; 2017 Jun; 27(6):534-542. PubMed ID: 28428027 [TBL] [Abstract][Full Text] [Related]
19. Angiotensin II Type 1 Receptor rs5186 Gene Variant Predicts Incident NAFLD and Associated Hypertension: Role of Dietary Fat-Induced Pro-Inflammatory Cell Activation. Musso G; Saba F; Cassader M; Paschetta E; De Michieli F; Pinach S; Framarin L; Berrutti M; Leone N; Parente R; Ayoubi Khajekini MT; Zarovska A; Gambino R Am J Gastroenterol; 2019 Apr; 114(4):607-619. PubMed ID: 30920415 [TBL] [Abstract][Full Text] [Related]
20. Differential effects of saturated and monounsaturated fatty acids on postprandial lipemia and incretin responses in healthy subjects. Thomsen C; Rasmussen O; Lousen T; Holst JJ; Fenselau S; Schrezenmeir J; Hermansen K Am J Clin Nutr; 1999 Jun; 69(6):1135-43. PubMed ID: 10357731 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]